Access

Article


Nature Medicine 9, 1383 - 1389 (2003)
Published online: 5 October 2003 | doi:10.1038/nm944

Multiple actions of systemic artemin in experimental neuropathy

Luis R Gardell1, Ruizhong Wang1, Chris Ehrenfels2, Michael H Ossipov1, Anthony J Rossomando2, Stephan Miller2, Carolyn Buckley2, Amber K Cai2,3, Albert Tse2, Susan F Foley2, BangJian Gong2, Lee Walus2, Paul Carmillo2, Dane Worley2, Carol Huang2,3, Thomas Engber2, Blake Pepinsky2, Richard L Cate2, Todd W Vanderah1, Josephine Lai1, Dinah W Y Sah2 & Frank Porreca1


The clinical management of neuropathic pain is particularly challenging. Current therapies for neuropathic pain modulate nerve impulse propagation or synaptic transmission; these therapies are of limited benefit and have undesirable side effects. Injuries to peripheral nerves result in a host of pathophysiological changes associated with the sustained expression of abnormal pain. Here we show that systemic, intermittent administration of artemin produces dose- and time-related reversal of nerve injury–induced pain behavior, together with partial to complete normalization of multiple morphological and neurochemical features of the injury state. These effects of artemin were sustained for at least 28 days. Higher doses of artemin than those completely reversing experimental neuropathic pain did not elicit sensory or motor abnormalities. Our results indicate that the behavioral symptoms of neuropathic pain states can be treated successfully, and that partial to complete reversal of associated morphological and neurochemical changes is achievable with artemin.


MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
Neurotrophic factors as novel therapeutics for neuropathic pain
Nature Reviews Drug Discovery Review (01 Jun 2003)
 See all 2 matches for Reviews

NEWS AND VIEWS
Breaking the pain barrier
Nature Medicine News and Views (01 Nov 2003)

RESEARCH
Functional regeneration of sensory axons into the adult spinal cord
Nature Letters to Editor (20 Jan 2000)
Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss
Nature Neuroscience Article (01 Nov 2003)
Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice
Nature Letters to Editor (26 Oct 2000)
 See all 4 matches for Research

$rb.Type.Code